The Securities and Exchange Commission recently charged a former pharmaceutical company executive and his longtime friend with insider trading, alleging that the friend generated more than $1 million in illicit profits by trading on tips from the former executive. Defendant Saran Sabrdaran was the former director of Drug Safety Risk Management at InterMune Inc., a public pharmaceutical company headquartered in California.